4.7 Review

Targeting ASIC3 for pain, anxiety, and insulin resistance

Journal

PHARMACOLOGY & THERAPEUTICS
Volume 134, Issue 2, Pages 127-138

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2011.12.009

Keywords

ASIC; APETx2; Inflammation; Postoperative pain; Cardiac ischemia; Heart failure

Funding

  1. Institute of Biomedical Sciences, Academia Sinica
  2. Taiwan Mouse Clinic
  3. National Science Council [NSC98-2320-b-001-019-MY3, NSC100-2321-B-001-018, NSC100-2325-B-001-30]
  4. Tzu Chi General Hospital [TCRDI-100-1]

Ask authors/readers for more resources

The acid-sensing ion channel 3 (ASIC3) is a pH sensor that responds to mild extracellular acidification and is predominantly expressed in nociceptors. There is much interest in targeting ASIC3 to relieve pain associated with tissue acidosis, and selective drugs targeting ASIC3 have been used to relieve acid-evoked pain in animal models and human studies. There is accumulating evidence that ASIC3 is widely expressed in many neuronal and non-neuronal cells, such as neurons in the brain and adipose cells, albeit to a lesser extent than in nociceptors. Asic3-knockout mice have reduced anxiety levels and enhanced insulin sensitivity, suggesting that antagonizing ASIC3 has additional benefits. This view is tempered by recent studies suggesting that Asic3-knockout mice may experience cardiovascular disturbances. Due to the development of ASIC3 antagonists as analgesics, we review here the additional benefits, safety, risks, and strategy associated with antagonizing ASIC3 function. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available